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Not least because of the nano-hype, a myriad of labs focuses their research on 
nanoparticles. Inexplicably, a collection of lab protocols was not available until 
now. That way, this book fills a gap by offering a basic set of methods for pre-
clinical characterization of nanomaterials provided by experienced people from 
the National Cancer Institute’s Nanotechnology Lab. 
Before starting the experimental work, reading chapter 2 dealing with the 
challenges of nanoparticle characterization is highly recommended. Due to the 
unique properties of nanoparticles, interference with standardized protocols can 
lead to false-positive or false-negative results. Being aware of these problems 
the assay design as well as the interpretation of results might be adapted 
accordingly. 
Each chapter starts with a short description of the basics, and after listing the 
materials necessary for the assay, mostly a detailed description of the protocol 
should allow for a successful experiment. Most useful, the section “notes” gives 
valuable hints towards pitfalls, selection of devices, data analysis, and 
interpretation of results. Finally, for a more detailed knowledge, a short list of 
references rounds off each chapter. 
As virtually impossible, this book offers not a complete, but a highly 
comprehensive and broad spectrum of protocols. The toolset provided starts 
with methods for physicochemical characterization of nanoparticles such as 
size, zeta potential, imaging methods (SEM, TEM, AFM) and molecular weight 
of dendrimers. To account for sterility, two versions of the limulus test as well as 
a general test for microbial contamination are given. The topic “in-vitro detection 
and quantitation” lists only methods for gold and fullerene nanoparticles, and 
should be extended to pharmaceutically relevant polymers in future. The often 
controversy discussed issue “cytotoxicity” is covered by a broad spectrum of 
different approaches: Estimation of cell-viability by MTT-  or LDH-assay, 
apoptotic potential by caspase activation assay, oxidative stress by even three 
different protocols comprising reactive oxygen production, lipid peroxidation and 
glutathione/oxidized glutathione determination as well as effects on lysosomes 
such as accumulation of autophagic vacuoles and total lysosome content. 
Finally, some light is shed on the influence of nanomaterials on blood 
constituents ranging from hemolysis, thrombogenicity and complement 
activation to chemotaxis. For the next edition of this high quality collection of 702  Book Review   
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protocols it would be desirable to include also techniques for elucidation of 
bioadhesivity, cell-binding, uptake and transcellular transport as required for ex-
vivo characterization of drug-loaded nanoparticles.  
All in all, this collection of lab-protocols is well recommended for scientists, 
starters in the field but also people dealing with regulatory issues in the field of 
nanomedicine. 
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